Skip to main content
. 2018 May 24;39(9):1544–1552. doi: 10.1038/aps.2017.188

Figure 3.

Figure 3

Discovery and validation of novel SMARCA2-BRD inhibitors. (A) Primary AlphaScreen high-throughput screening results. (B) AlphaScreen TruHits kit validation. (C) Inhibitory activities of DCSM06. (D) SPR assay demonstrated binding between SMARCA2-BRD and DCSM06.